A
Price
$138.04
Change
-$0.19 (-0.14%)
Updated
Oct 14 closing price
Capitalization
39.13B
47 days until earnings call
Intraday Buy/Sell Signals
MTD
Price
$1303.04
Change
+$18.30 (+1.42%)
Updated
Oct 14 closing price
Capitalization
26.84B
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

A vs MTD

Header iconA vs MTD Comparison
Open Charts A vs MTDBanner chart's image
Agilent Technologies
Price$138.04
Change-$0.19 (-0.14%)
Volume$1.14M
Capitalization39.13B
Mettler-Toledo International
Price$1303.04
Change+$18.30 (+1.42%)
Volume$199.66K
Capitalization26.84B
A vs MTD Comparison Chart in %
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. MTD commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and MTD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (A: $138.04 vs. MTD: $1303.04)
Brand notoriety: A and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 68% vs. MTD: 147%
Market capitalization -- A: $39.13B vs. MTD: $26.84B
A [@Medical Specialties] is valued at $39.13B. MTD’s [@Medical Specialties] market capitalization is $26.84B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 2 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 2 green, 3 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while MTD’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 4 bearish.
  • MTD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MTD is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -0.38% price change this week, while MTD (@Medical Specialties) price change was -0.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.74%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +51.93%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (-0.74% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($39.1B) has a higher market cap than MTD($26.8B). MTD (33.04) and A (32.25) have similar P/E ratio . MTD YTD gains are higher at: 6.485 vs. A (3.397). A has higher annual earnings (EBITDA): 1.8B vs. MTD (1.22B). A has more cash in the bank: 1.54B vs. MTD (61.8M). MTD has less debt than A: MTD (2.18B) vs A (3.41B). A has higher revenues than MTD: A (6.79B) vs MTD (3.87B).
AMTDA / MTD
Capitalization39.1B26.8B146%
EBITDA1.8B1.22B148%
Gain YTD3.3976.48552%
P/E Ratio32.2533.0498%
Revenue6.79B3.87B176%
Total Cash1.54B61.8M2,484%
Total Debt3.41B2.18B156%
FUNDAMENTALS RATINGS
A vs MTD: Fundamental Ratings
A
MTD
OUTLOOK RATING
1..100
198
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
6066
SMR RATING
1..100
453
PRICE GROWTH RATING
1..100
4651
P/E GROWTH RATING
1..100
3161
SEASONALITY SCORE
1..100
7575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (19) in the Biotechnology industry is significantly better than the same rating for MTD (100) in the Medical Specialties industry. This means that A’s stock grew significantly faster than MTD’s over the last 12 months.

A's Profit vs Risk Rating (60) in the Biotechnology industry is in the same range as MTD (66) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for A (45) in the Biotechnology industry. This means that MTD’s stock grew somewhat faster than A’s over the last 12 months.

A's Price Growth Rating (46) in the Biotechnology industry is in the same range as MTD (51) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

A's P/E Growth Rating (31) in the Biotechnology industry is in the same range as MTD (61) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMTD
RSI
ODDS (%)
Bearish Trend 8 days ago
51%
Bullish Trend 8 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
63%
Bearish Trend 8 days ago
70%
Momentum
ODDS (%)
Bullish Trend 8 days ago
65%
Bullish Trend 8 days ago
72%
MACD
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 8 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
64%
Bullish Trend 8 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
60%
Bullish Trend 8 days ago
60%
Advances
ODDS (%)
Bullish Trend 13 days ago
61%
Bullish Trend 10 days ago
62%
Declines
ODDS (%)
Bearish Trend 9 days ago
60%
Bearish Trend 17 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
56%
Bullish Trend 8 days ago
68%
Aroon
ODDS (%)
Bullish Trend 8 days ago
61%
Bearish Trend 8 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUST10.220.24
+2.40%
Direxion Daily Gold Miners Bear 2X ETF
AVK12.980.05
+0.39%
Advent Convertible and Income Fund
IFEB29.370.03
+0.10%
Innovator Intl Dev Pwr Bffr ETF - Feb
CCZ60.85N/A
N/A
Comcast Holdings Corp
IOO119.40-0.74
-0.62%
iShares Global 100 ETF

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-0.14%
MTD - A
85%
Closely correlated
+1.42%
TMO - A
80%
Closely correlated
+0.24%
WAT - A
79%
Closely correlated
-0.95%
RVTY - A
78%
Closely correlated
+0.18%
DHR - A
76%
Closely correlated
+0.49%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+1.42%
A - MTD
82%
Closely correlated
-0.14%
RVTY - MTD
79%
Closely correlated
+0.18%
TMO - MTD
77%
Closely correlated
+0.24%
WAT - MTD
75%
Closely correlated
-0.95%
BRKR - MTD
71%
Closely correlated
+0.80%
More